Despite no revenue yet, the company expects to have enough cash to fund the 2024 fiscal year. The post Small Pharma Posts C$23 Million Loss for...
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights The post Small Pharma Reports 2023 Financial...
Psychedelic stocks have a bright future with 13.5% compound annual growth expected through 2029. That growth will certainly draw in investment funding...
We compare the journeys of the cannabis and psychedelic industries in their pursuit of legalization. The post The Road to Legal Psychedelics: Is Cannabis...
With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research...
Legal psychedelic treatment doesn’t mean much if no one can afford it. The cost of psychedelic-assisted therapy is undoubtedly high, and ensuring equitable...
As battlespace sensors proliferate and data increases, commanders can easily find themselves in an information paradox: drowning in data, but starving...
Microbes have lost their monopoly as the sole source of new enzymes that can be easily programmed to make precise edits to the genome. Two independent...
Cybin has reported audited financial results for fiscal year 2023 and recent business highlights. The post Cybin Reports 2023 Financial Results and Business...
Local initiatives and cultural changes are playing a pivotal role in spearheading decriminalization and legalization efforts and the future of legal psychedelics. The...
The Daily Hit is a recap of the top financial news stories for June 27, 2023. On the Site Florida Governor Signs Medical Marijuana Bill Despite...
Cybin also reached a common share purchase agreement with Lincoln Park Capital Fund. The post Cybin Posts C$47.5 Million Loss for 2023 Fiscal Year appeared...
PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA The post PharmaTher Initiates Filing of Abbreviated...
Stella also plans to open a new treatment clinic in Irvine, California. The post Stella to Acquire Some of Field Trip’s Psychedelics Therapy Clinics...
The U.S. Food and Drug Administration (FDA) has released a groundbreaking draft guidance to provide crucial insights for researchers exploring The post...